ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 76

Applying 2016 MAS Criteria to Systemic onset Juvenile Idiopathic Arthritis Patients with Diagnosis of Macrophage Activation Syndrome

Ezgi Baris1,2, Edwin Anderson3 and Fatma Dedeoglu1, 1Division of Immunology, Rheumatology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 2Pediatrics, Marmara University, Istanbul, Turkey, 3Division of Immunology, Boston Children's Hospital, Boston, MA

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: classification criteria and macrophage activation syndrome, Systemic JIA

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Session Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: Macrophage activation syndrome (MAS) is the result of uncontrolled systemic inflammation, which can sometimes complicate systemic onset juvenile idiopathic arthritis (SoJIA). MAS classification criteria for SoJIA are recently developed. We aimed to apply the newly developed criteria to SoJIA patients with diagnosis of MAS.

Methods: We retrospectively analyzed our patients diagnosed with SoJIA between 1996-2015. Clinical features and laboratory parameters of patients who were diagnosed with MAS are reassessed according to 2016 criteria for MAS in SoJIA.

Results: 27 patients (32.1%, 13 boys and 14 girls) out of the 84 patients diagnosed with SoJIA, developed MAS. 7 patients had recurrent MAS episodes. Mean age of diagnosis for SoJIA was 5.8 ± 4.5 years and for the first MAS episode was 6.7 ± 5.2 years. 20 patients (22.9%) developed MAS at presentation of SoJIA while 7 patients developed it during the course of SoJIA. Among these 7, two patients were off treatment and the remaining patients were on biologic disease modifiying anti-rheumatic drugs (DMARDs) including infliximab, etanercept, anakinra, canakinumab and tocilizumab, in combination with classic DMARDs, except for one patient treated only with non-biologic agents. 14 patients fulfilled the 2016 criteria of MAS for SoJIA. Two patients did not have fever but met the lab criteria. Ferritin levels were not high enough in two patients. 11 patients had thrombocytopenia, 22 patients had increased AST, 9 had increased triglyceride and 10 patients had hypofibrinogenemia. No death occurred during the course of MAS.

Conclusion: Even if the criteria are not met, a high index of suspicion for MAS in SoJIA may be lifesaving. In addition to recently developed MAS criteria for SoJIA, following the trend of laboratory values can help to recognize a “developing MAS” and to treat accordingly early in the course.


Disclosure: E. Baris, None; E. Anderson, None; F. Dedeoglu, None.

To cite this abstract in AMA style:

Baris E, Anderson E, Dedeoglu F. Applying 2016 MAS Criteria to Systemic onset Juvenile Idiopathic Arthritis Patients with Diagnosis of Macrophage Activation Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/applying-2016-mas-criteria-to-systemic-onset-juvenile-idiopathic-arthritis-patients-with-diagnosis-of-macrophage-activation-syndrome/. Accessed May 19, 2022.
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/applying-2016-mas-criteria-to-systemic-onset-juvenile-idiopathic-arthritis-patients-with-diagnosis-of-macrophage-activation-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.